Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedNov 7, 2018MenoPowerCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0109-2019Class IITerminatedNov 7, 2018Woman PowerCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0108-2019Class IITerminatedNov 7, 2018Brain PowerCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0107-2019Class IITerminatedNov 7, 2018Man PowerCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0106-2019Class IITerminatedNov 7, 2018Rejuvenation PlusCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0105-2019Class IITerminatedOct 31, 2018Bumetanide TabletsFailed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.Upsher Smith Laboratories, Inc. · D-0281-2019Class IITerminatedOct 31, 2018Bumetanide TabletsFailed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.Upsher Smith Laboratories, Inc. · D-0280-2019Class IIITerminatedOct 31, 2018Prednisolone and Gatifloxacin Ophthalmic SolutionPresence of precipitatePromise Pharmacy LLC · D-0239-2019Class IITerminatedOct 31, 2018Lidocaine 1% + Epinephrine 1:100Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.RXQ Compounding LLC · D-0130-2019Class IITerminatedOct 31, 2018Metoprolol Succinate Extended Release TabletsFailed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.Teva Pharmaceuticals USA · D-0129-2019Class IITerminatedOct 31, 2018PIO&METFORMIN 15/1000 mg Tab 1Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0102-2019Class IITerminatedOct 31, 2018Metformin Hydrochloride Extended Release Tablets 1000 mgDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0101-2019Class IITerminatedOct 31, 2018Metformin Hydrochloride Extended Release Tablets 1000 mgDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0100-2019Class IITerminatedOct 31, 2018Metformin Hydrochloride Extended Release TabletsDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0099-2019Class IITerminatedOct 31, 2018FortametDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0098-2019Class IITerminatedOct 31, 2018Paliperidone Extended Release Tablets 9 mgDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0097-2019Class IITerminatedOct 31, 2018Paliperidone Extended Release Tablets 3 mgDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0096-2019Class IITerminatedOct 31, 2018Meropenem for InjectionLack of assurance of sterility: loss of container integrity.Pfizer Inc. · D-0095-2019Class IITerminatedOct 31, 2018Cidofovir injection 375 mg/mLLack of Assurance of Sterility: complaints received about dried powder on the outside of the bottleHeritage Pharmaceuticals, Inc. · D-0094-2019Class IITerminatedOct 31, 2018Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tabletsCGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.RemedyRepack Inc. · D-0093-2019Class IITerminatedOct 31, 2018Fluocinolone Acetonide Topical SolutionFailed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysisLupin Somerset · D-0092-2019Class IITerminatedOct 31, 2018Cyclosporine 1% Human Eye DropsLack of Process ControlsWestlab Pharmacy, Inc. dba Westlab Pharmacy · D-0091-2019Class IITerminatedOct 31, 2018ADAA Cataract DropsLack of Process ControlsWestlab Pharmacy, Inc. dba Westlab Pharmacy · D-0090-2019Class IITerminatedOct 31, 2018Alprostadil 500 mcg/mL InjectableIncorrect Product FormulationWestlab Pharmacy, Inc. dba Westlab Pharmacy · D-0089-2019Class IIITerminatedOct 31, 2018Testosterone Topical SolutionDefective Container: Repetitive complaints received indicating pump not working.Lupin Pharmaceuticals Inc. · D-0087-2019Class IITerminatedOct 31, 2018Cortaid 12-Hour Advanced Anti-itch CreamCGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No...Valeant Pharmaceuticals North America LLC · D-0086-2019Class IITerminatedOct 31, 2018Cortaid Maximum Strength CreamCGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No...Valeant Pharmaceuticals North America LLC · D-0085-2019Class IITerminatedOct 31, 2018Cortaid Intensive Therapy Cooling SprayCGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No...Valeant Pharmaceuticals North America LLC · D-0084-2019Class IITerminatedOct 31, 2018HydrOXYzine HYDROCHLORIDE SYRUPCGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.Lannett Company, Inc. · D-0083-2019Class IIITerminatedOct 24, 2018Temozolomide capsulesFailed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.Amerigen Pharmaceuticals Inc. · D-0249-2019Class IITerminatedOct 24, 2018Clonazepam Orally Disintegrating Tablets USPFailed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.Teva Pharmaceuticals USA · D-0082-2019Class IITerminatedOct 24, 2018Family Dollar Saline Nasal Spray 4.25 oz. canCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0080-2019Class IITerminatedOct 24, 2018Finafta BabyCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0079-2019Class IITerminatedOct 24, 2018Rexall, Extra Moisturizing No Drip Nasal SprayCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0078-2019Class IITerminatedOct 24, 2018Rexall, Extra Moisturizing No Drip Nasal SprayCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0077-2019Class IITerminatedOct 24, 2018Rexall, Sinus Nasal Pump MistCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0076-2019Class IITerminatedOct 24, 2018Rhinall Nasal Decongestant Nasal SprayCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0075-2019Class ITerminatedOct 24, 2018Sinus ReliefMicrobial Contamination of Non-Sterile Products: Failed microbiological testing for Pseudomonas aeruginosa.Product Quest Manufacturing LLC · D-0074-2019Class IITerminatedOct 24, 2018CVS HealthSubpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.Product Quest Manufacturing LLC · D-0073-2019Class IITerminatedOct 24, 2018Mushatt's No. 9Microbial Contamination of Non-Sterile Products and Subpotent Drug: failure for microbiological growth exceeding specification and low out of specification assay results...Product Quest Manufacturing LLC · D-0072-2019

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.